The lowest-rated GLP-1 programs we track, and why
Most comparison sites will not publish the bottom of their own table. These are the 5 lowest current published scores in ours, each with the specific documented reason it sits there.
5 of these 5 are our own affiliate partners. We earn a commission when a reader signs up with them, and they keep the same published score anyway. Payment never moves a program up our rankings, and it does not move one off this page either.
Each entry names a comparable alternative: the closest-priced program that scores 7.0 or higher and at least two points above the one it replaces. Closest price, not cheapest and not highest-scoring, because swapping a $69 program for a $249 one is an upsell rather than an alternative. 4 of the 5 alternatives below pay us and 1 do not, which is what picking on price and score alone produces.
Ozempic is listed at $1,299 and Zepbound at $1,399 per four-week cycle. No longer-plan brand discount is published. Compare the same prescribed brand, dose, supply and included services before choosing a cash-pay offer
Consider instead: Enhance MD (7.8/10 · from $212/mo), the closest-priced program scoring 7.0 or better.
No verified dispensing pharmacy in the sources reviewed
Consider instead: SynergyRx (7.6/10 · from $199/mo), the closest-priced program scoring 7.0 or better.
Trustpilot has withheld Trimi's star rating for a breach of its review guidelines and says it removed a number of fake reviews. Of the 55 reviews displayed, 64 percent are one star (checked 2026-09-23). Recent reviewers report fulfillment, refund and certificate-of-analysis concerns; these individual accounts do not establish medication quality
Consider instead: Bodybuilding Health+ (7.2/10 · $179/mo month-to-month), the closest-priced program scoring 7.0 or better.
A small independent review sample: Trustpilot showed 3.1/5 from 7 reviews on October 1, 2026. It cannot establish a typical experience or corroborate the homepage's customer-count claim
Consider instead: Sesame Care (7.9/10 · published $99/mo; total not verified), the closest-priced program scoring 7.0 or better.
The $59 and $69 medication headlines exclude a required $199 annual membership after a 21-day trial
Consider instead: Embody (7.3/10 · from $69/mo), the closest-priced program scoring 7.0 or better.
A low score is not an accusation of wrongdoing. It means the program was weaker than its peers on our five weighted dimensions at the last verification pass, most often on price transparency or published clinical detail. Scores change when the underlying facts change, in either direction.